TREM2 regulates microglial cell activation in response to demyelination in vivo

Document Type

Article

Abstract

Microglia are phagocytic cells that survey the brain and perform neuroprotective functions in response to tissue damage, but their activating receptors are largely unknown. Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial immunoreceptor whose loss-of-function mutations in humans cause presenile dementia, while genetic variants are associated with increased risk of neurodegenerative diseases. In myeloid cells, TREM2 has been involved in the regulation of phagocytosis, cell proliferation and inflammatory responses in vitro. However, it is unknown how TREM2 contributes to microglia function in vivo. Here, we identify a critical role for TREM2 in the activation and function of microglia during cuprizone (CPZ)-induced demyelination. TREM2-deficient (TREM2(-/-)) mice had defective clearance of myelin debris and more axonal pathology, resulting in impaired clinical performances compared to wild-type (WT) mice. TREM2(-/-) microglia proliferated less in areas of demyelination and were less activated, displaying a more resting morphology and decreased expression of the activation markers MHC II and inducible nitric oxide synthase as compared to WT. Mechanistically, gene expression and ultrastructural analysis of microglia suggested a defect in myelin degradation and phagosome processing during CPZ intoxication in TREM2(-/-) microglia. These findings place TREM2 as a key regulator of microglia activation in vivo in response to tissue damage.

Medical Subject Headings

Animals; Brain (metabolism, pathology); Cell Proliferation; Chelating Agents (toxicity); Cuprizone (toxicity); Demyelinating Diseases (chemically induced, metabolism, pathology); Disease Models, Animal; Immunohistochemistry; Membrane Glycoproteins (metabolism); Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia (metabolism); Microscopy, Immunoelectron; Oligonucleotide Array Sequence Analysis; Real-Time Polymerase Chain Reaction; Receptors, Immunologic (metabolism)

Publication Date

3-1-2015

Publication Title

Acta neuropathologica

E-ISSN

1432-0533

Volume

129

Issue

3

First Page

429

Last Page

47

PubMed ID

25631124

Digital Object Identifier (DOI)

10.1007/s00401-015-1388-1

Share

COinS